Decentralized Trial Technology Resources

  1. What Universalized Terminology Means For Decentralized Research 10/26/2022

    Many DCT stakeholders have attempted to release terminology guides as it relates to their own dealings, however, there had never been a wide range of universalized DCT terms until now. 

  2. Preparing Studies With eConsent For IRB Approval 6/7/2023

    Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.

  3. eCOA Predictions For 2022 5/2/2022

    Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.

  4. The Building Blocks Of DCT: How To Create A Seamless Experience Across eConsent, eCOA, And More 3/29/2022

    With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies. 

  5. Deconstructing Central Rating In Clinical Trials 1/27/2025

    Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this

  6. Deriving Reliable Clinical Outcome Scores From Continuous DHT Data 6/10/2025

    DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.

  7. Redefining Evidence Generation In Modern Clinical Trials 8/2/2024

    As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.

  8. The Transformative Impact Of EDC Systems In 2025 5/6/2025

    The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

  9. How DCTs Became The New Standard 10/30/2023

    See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

  10. Data Quality And How It Impacts Clinical Trials

    Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.